Dennis Weissman is a widely respected independent analyst, consultant and thought leader who has worked in the clinical laboratory and anatomic pathology sectors for over three decades. He founded a national information company serving the diagnostic industry, is now actively engaged in providing M&A advisory services for lab and AP organizations and remains a popular conference and workshop speaker before state, regional and national organizations.
- England & Company
Mr. Weissman serves as a senior healthcare advisor to England & Company, a DC-based investment bank focused on providing M&A advisory, financial restructuring, and capital raising services to middle market healthcare companies with a concentration in anatomic and clinical diagnostic laboratories, medical devices, IT and other healthcare services.
- G-2 Intelligence
Offering a wide variety of information products and research services to the diagnostic industry, the company was founded by Mr. Weissman in 1979 and where he continues to advise BNA Subsidiaries which acquired the firm in 1999.
- Slone Partners
Mr. Weissman serves in an advisory capacity to Slone Partners, a national recruitment and leadership development company exclusively serving the clinical and anatomic laboratory sectors.
Mr. Weissman acts as a Consultant & Advisory Board Member for OncoMDx, a Silicon Valley based CLIA certified esoteric laboratory which develops novel, proprietary and affordable cancer diagnostics for early detection and patient satisfaction.
- Gerson Lehrman Group
Mr. Weissman is a expert healthcare consultant for the Gerson Lehrman Group